Soc. Generale Call 105 DVA 20.09..../ DE000SQ3HB59 /
05/09/2024 09:20:16 | Chg.+0.01 | Bid16:30:50 | Ask16:30:50 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.83EUR | +0.26% | 3.98 Bid Size: 10,000 |
- Ask Size: - |
DaVita Inc | 105.00 USD | 20/09/2024 | Call |
GlobeNewswire
24/06
BayMark Health Services Announces Leadership Transition: David White Steps Down as CEO; Marshal Salo...
Newsfile Corp
18/06
Healing Realty Trust Closes First Tranche of Series A to Expand Clinic-Focused Portfolio for a New G...
GlobeNewswire
26/04
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
17/11/2023
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
15/08/2023
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
21/03/2022
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
07/03/2022
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
10/02/2022
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
07/10/2021
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
01/10/2021
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors